ArticlePsychiatric research and clinical practice2026
Prevalence and Clinical Impact of Attention Deficit Hyperactivity Disorder in Patients With Severe Borderline Personality Disorder.
Article in Psychiatric research and clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence and Clinical Impact of Attention Deficit Hyperactivity Disorder in Patients With Severe Borderline Personality Disorder.Psychiatric research and clinical practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to estimate the prevalence and assess the clinical impact of ADHD in patients with severe borderline personality disorder (BPD) treated in a specialized unit. Methods: Cross-sectional study of a sample of 145 patients diagnosed with BPD according to DSM-5 criteria, consecutively referred by outpatient psychiatrists to a Personality Disorders Unit. ADHD symptoms were assessed using the self-reported long version of the Conners Adult ADHD Rating Scale (CAARS-S:L). Groups were compared based on ADHD presence. Hypothesis testing was performed and variables with statistically significant differences were further analyzed using linear correlation and simple linear regression analyses. Results: Of the 145 BPD patients, 88 (60.7%) scored above 70 on the CAARS S:L. The BPD-ADHD group showed significantly greater anxiety, depression, impulsivity, poorer global functioning, and more severe BPD symptoms. Among ADHD domains, inattention is the one that best predicts the clinical severity of BPD. Conclusions: The coexistence of BPD and ADHD is associated with greater clinical severity and poorer overall functioning. Inattention, in particular, emerges as a key factor explaining BPD symptom variability. Relevance to Clinical Practice: These findings emphasize the importance of systematically screening for ADHD symptoms in patients with severe BPD. Recognizing and addressing this comorbidity may allow clinicians to design more comprehensive treatment strategies, reduce clinical severity, and improve functional outcomes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.